Trials / Completed
CompletedNCT00385190
Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men
An Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of Study Drug Administred Orally to Healthy Japanese Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to assess the safety and tolerability of ascending multiple oral doses of HCV-796 in healthy Japanese male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HCV-796 |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2006-11-01
- Completion
- 2006-12-01
- First posted
- 2006-10-06
- Last updated
- 2009-08-18
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00385190. Inclusion in this directory is not an endorsement.